XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.0.1
Unaudited Condensed Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Treasury Stock
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Beginning balance (in shares) at Jun. 30, 2020     48,147     5,975    
Beginning balance at Jun. 30, 2020 $ 392,334 $ 56 $ 48 $ 764,906 $ (48,675) $ (143,333) $ (180,612) $ 56
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock for employee stock purchase plan and upon exercise of stock options (in shares)           (75)    
Issuance of common stock for employee stock purchase plan and upon exercise of stock options 2,168     379   $ 1,789    
Vesting of restricted stock awards (in shares)     543          
Vesting of restricted stock awards 1   $ 1          
Issuance of common stock in connection with acquisition (in shares)     166          
Issuance of common stock in connection with acquisition 8,183     8,183        
Repurchase of common stock to be held in treasury (in shares)           238    
Repurchase of common stock to be held in treasury (10,755)         $ (10,755)    
Stock compensation plan expense 22,162     22,162        
Minimum pension liability adjustments, net of tax (564)       (564)      
Net loss (4,224)           (4,224)  
Unrealized loss on available for sale securities, net of tax (35)       (35)      
Change in fair value on interest rate hedging instruments 912       912      
Foreign currency translation adjustment 22,749       22,749      
Ending balance (in shares) at Dec. 31, 2020     48,856     6,138    
Ending balance at Dec. 31, 2020 432,987   $ 49 795,630 (25,613) $ (152,299) (184,780)  
Beginning balance (in shares) at Sep. 30, 2020     48,560     5,900    
Beginning balance at Sep. 30, 2020 422,416   $ 49 783,457 (39,381) $ (141,544) (180,165)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Vesting of restricted stock awards (in shares)     296          
Repurchase of common stock to be held in treasury (in shares)           238    
Repurchase of common stock to be held in treasury (10,755)         $ (10,755)    
Stock compensation plan expense 12,173     12,173        
Minimum pension liability adjustments, net of tax (331)       (331)      
Net loss (4,615)           (4,615)  
Unrealized loss on available for sale securities, net of tax (10)       (10)      
Change in fair value on interest rate hedging instruments 466       466      
Foreign currency translation adjustment 13,643       13,643      
Ending balance (in shares) at Dec. 31, 2020     48,856     6,138    
Ending balance at Dec. 31, 2020 432,987   $ 49 795,630 (25,613) $ (152,299) (184,780)  
Beginning balance (in shares) at Jun. 30, 2021     49,294     6,057    
Beginning balance at Jun. 30, 2021 456,234   $ 49 819,392 (16,081) $ (150,282) (196,844)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock for employee stock purchase plan and upon exercise of stock options (in shares)           (78)    
Issuance of common stock for employee stock purchase plan and upon exercise of stock options 2,313     278   $ 2,035    
Vesting of restricted stock awards (in shares)     515          
Vesting of restricted stock awards 1   $ 1          
Repurchase of common stock to be held in treasury (in shares)           1,163    
Repurchase of common stock to be held in treasury (50,000)         $ (50,000)    
Stock compensation plan expense 27,525     27,525        
Minimum pension liability adjustments, net of tax (212)       (212)      
Net loss (21,541)           (21,541)  
Unrealized loss on available for sale securities, net of tax 1       1      
Change in fair value on interest rate hedging instruments 1,323       1,323      
Foreign currency translation adjustment (4,516)       (4,516)      
Ending balance (in shares) at Dec. 31, 2021     49,809     7,142    
Ending balance at Dec. 31, 2021 411,128   $ 50 847,195 (19,485) $ (198,247) (218,385)  
Beginning balance (in shares) at Sep. 30, 2021     49,586     6,496    
Beginning balance at Sep. 30, 2021 440,739   $ 49 833,563 (21,376) $ (169,746) (201,751)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Vesting of restricted stock awards (in shares)     223          
Vesting of restricted stock awards 1   $ 1          
Repurchase of common stock to be held in treasury (in shares)           646    
Repurchase of common stock to be held in treasury (28,501)         $ (28,501)    
Stock compensation plan expense 13,632     13,632        
Minimum pension liability adjustments, net of tax (70)       (70)      
Net loss (16,634)           (16,634)  
Unrealized loss on available for sale securities, net of tax 0              
Change in fair value on interest rate hedging instruments 907       907      
Foreign currency translation adjustment 1,054       1,054      
Ending balance (in shares) at Dec. 31, 2021     49,809     7,142    
Ending balance at Dec. 31, 2021 $ 411,128   $ 50 $ 847,195 $ (19,485) $ (198,247) $ (218,385)